Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sadal Refae

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Current Opinion in Oncology|September 9, 2016
Extended anti-HER2 therapy in early breast cancer: longer beats shorter?Sadal Refae, Barbara Pistilli, Suzette Delaloge
Critical Reviews in Oncology/Hematology|July 14, 2019
Germinal immunogenetics as a predictive factor for immunotherapySadal Refae, Jocelyn Gal, Patrick Brest, et al.
Trends in Genetics : TIG|August 24, 2020
Host Polymorphisms May Impact SARS-CoV-2 InfectivityPatrick Brest, Sadal Refae, Baharia Mograbi, et al.
Cancer Genetics|August 31, 2015
Molecular cytogenetics of pediatric adipocytic tumorsBérengère Dadone, Sadal Refae, Camille Lemarié-Delaunay, et al.
British Journal of Cancer|May 6, 2022
Checkpoint inhibitors in a marriage: consented or arranged?Patrick Brest, Sadal Refae, Baharia Mograbi, et al.
Investigational New Drugs|June 6, 2020
Correction to: Germinal Immunogenetics predict treatment outcome for PD-1/PD-L1 checkpoint inhibitorsSadal Refae, Jocelyn Gal, Nathalie Ebran, et al.
Scientific Reports|June 13, 2020
Author Correction: Hyperprogression under Immune Checkpoint Inhibitor: a potential role for germinal immunogeneticsSadal Refae, Jocelyn Gal, Patrick Brest, et al.
Scientific Reports|February 29, 2020
Hyperprogression under Immune Checkpoint Inhibitor: a potential role for germinal immunogeneticsSadal Refae, Jocelyn Gal, Patrick Brest, et al.
Investigational New Drugs|August 13, 2019
Germinal Immunogenetics predict treatment outcome for PD-1/PD-L1 checkpoint inhibitorsSadal Refae, Jocelyn Gal, Nathalie Ebran, et al.
Oral Oncology|April 11, 2018
Microsatellite instability associated with durable complete response to PD-L1 inhibitor in head and neck squamous cell carcinomaMagalie P Tardy, Ilaria Di Mauro, Nathalie Ebran, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Current Opinion in Oncology|September 9, 2016
Extended anti-HER2 therapy in early breast cancer: longer beats shorter?Sadal Refae, Barbara Pistilli, Suzette Delaloge
Critical Reviews in Oncology/Hematology|July 14, 2019
Germinal immunogenetics as a predictive factor for immunotherapySadal Refae, Jocelyn Gal, Patrick Brest, et al.
Trends in Genetics : TIG|August 24, 2020
Host Polymorphisms May Impact SARS-CoV-2 InfectivityPatrick Brest, Sadal Refae, Baharia Mograbi, et al.
Cancer Genetics|August 31, 2015
Molecular cytogenetics of pediatric adipocytic tumorsBérengère Dadone, Sadal Refae, Camille Lemarié-Delaunay, et al.
British Journal of Cancer|May 6, 2022
Checkpoint inhibitors in a marriage: consented or arranged?Patrick Brest, Sadal Refae, Baharia Mograbi, et al.
Investigational New Drugs|June 6, 2020
Correction to: Germinal Immunogenetics predict treatment outcome for PD-1/PD-L1 checkpoint inhibitorsSadal Refae, Jocelyn Gal, Nathalie Ebran, et al.
Scientific Reports|June 13, 2020
Author Correction: Hyperprogression under Immune Checkpoint Inhibitor: a potential role for germinal immunogeneticsSadal Refae, Jocelyn Gal, Patrick Brest, et al.
Scientific Reports|February 29, 2020
Hyperprogression under Immune Checkpoint Inhibitor: a potential role for germinal immunogeneticsSadal Refae, Jocelyn Gal, Patrick Brest, et al.
Investigational New Drugs|August 13, 2019
Germinal Immunogenetics predict treatment outcome for PD-1/PD-L1 checkpoint inhibitorsSadal Refae, Jocelyn Gal, Nathalie Ebran, et al.
Oral Oncology|April 11, 2018
Microsatellite instability associated with durable complete response to PD-L1 inhibitor in head and neck squamous cell carcinomaMagalie P Tardy, Ilaria Di Mauro, Nathalie Ebran, et al.
Pageof 2